Aryavan Enterprise Ltd
- Market cap
- ₹ 47 Cr.
- P/E
- 15.8x
- P/B
- 1.59x
- 52-week range
- 34.51 – 78
- ROE
- 11%
- ROCE
- 14.9%
- Dividend yield
- 0.7%
- Debt / equity
- 0.1
- Sector
- Industrial Products
- Industry
- Iron & Steel Products
- Listed on
- BSE
About
Ecofinity Atomix Limited is an India-based company, which is focused on manufacturing pharmaceutical products. The Company, through its subsidiary, Padmavati Chemicals, is engaged in the business of manufacturing of chemical and its related products.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Iron & Steel Products: 148 companies →Aryavan Enterprise Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)15.8 against a typical 18.9: cheaper than most peers (1st = cheapest).61st of 146
- Sales growth+10.5% against a typical +13.1% from a year earlier.62nd of 117
- Profit growth−3.3% against a typical +26.2% from a year earlier.75th of 105
- Share price, 3 months+11.2% against a typical −4.5%.27th of 134
- Size₹ 47 Cr. market value against a typical ₹ 156.5 Cr. (1st = largest).93rd of 135
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 0 | 0 | 0 | 0 | 9 | 14 | 15 | 11 | 10 | 25 | 16 |
| Expenses | 2 | 1 | 0 | 0 | 0 | 9 | 13 | 14 | 10 | 10 | 24 | 15 |
| Operating Profit | −0 | −0 | 0 | −0 | −0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| OPM % | −5.6% | −121.6% | 25% | — | −25% | 3.2% | 6.3% | 5.8% | 4.2% | 2.3% | 5.1% | 4.4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | −0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 |
| Tax % | 0% | 0% | 8.1% | — | 0% | 30.6% | 20.6% | 32.2% | 18.1% | 29% | 26.7% | 25.6% |
| Net Profit | −0 | −0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS in Rs | −0.13 | −1.17 | 0.88 | 0 | 0.13 | 0.39 | 0.88 | 0.83 | 0.76 | 1.22 | 1.61 | 0.83 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 5%
- 5 Years
- —
- 3 Years
- —
- TTM
- 53%
- 10 Years
- 37%
- 5 Years
- —
- 3 Years
- —
- TTM
- 120%
- 10 Years
- 15%
- 5 Years
- 29%
- 3 Years
- 34%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Aryavan Enterprise Ltd | ₹ 74.05 | ₹ 47 Cr. | 15.8x | 1.6x | 11% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 38.2x | 5.5x | — | 19.8% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 93.5x | 14.6x | — | 26.1% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 77.1x | 20.4x | — | 13.7% |
| Zydus Lifesciences | ₹ 1,127.85 | ₹ 1,12,503 Cr. | 22.1x | 4.4x | — | 15.7% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 27.7x | 3.3x | — | 11.9% |
Prices are delayed and for information only. Nothing on this page is investment advice.